Avneet Singh, MD
Cardiovascular Disease · Kew Gardens, NYNPI 1487741872
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Medtronic at 47.9% of the total.
Across 150 payments — averaging $70.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$937
- Boston Scientific$865
- Shockwave Medical, Inc$744
- Edwards Lifesciences$715
- Cardiovascular Systems Inc.$492
- plus $2K from 10 others
Across 22 payments — averaging $12,228 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$269K
What the payments were for
- Food & beverage$10,550100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 98 | $5,055 |
| Abbott | 9 | $937 |
| Boston Scientific | 11 | $865 |
| Shockwave Medical, Inc | 5 | $744 |
| Edwards Lifesciences | 6 | $715 |
| Cardiovascular Systems Inc. | 3 | $492 |
| Philips North America LLC | 3 | $372 |
| Siemens Medical Solutions USA, Inc. | 3 | $345 |
| Abiomed | 4 | $318 |
| Inari Medical, Inc. | 2 | $240 |
| Stryker | 1 | $158 |
| Endotronix, Inc. | 1 | $135 |
| E.r. Squibb & Sons, L.L.C. | 1 | $118 |
| Teleflex LLC | 1 | $21 |
| Penumbra, Inc. | 1 | $19 |
| Chiesi USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYMPLICITY G3$1,161
- COREVALVE EVOLUT R$1,123
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$688
- Resolute$514
- ONYX FRONTIER$409
- COBALT DR MRI SURESCAN$346
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$337
- Diamondback Coronary$309
- OPTIS$272
- Impella$272
- FLOWTRIEVER CATHETER, S$240
- CT THROMBECTOMY SYSTEM KIT$240
- Diamondback Peripheral$176
- XIENCE SIERRA$175
- Polaris Ultra$172
- RESOLUTE ONYX$161
- FlowTriever$158
- AngioSculpt CV RX$150
- GALLANT$146
- CORDELLA PULOMONARY ARTERY PRESSURE SENSOR$135
How this compares
$10,550 in reported general payments places this provider in the 80th percentile of 2,302 cardiovascular disease providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 52 | $68,107 |
| EntrestoSacubitril/Valsartan | 48 | $44,027 |
| BrilintaTicagrelor | 11 | $12,796 |
| Atorvastatin Calcium | 199 | $2,582 |
| Metoprolol Succinate | 127 | $1,902 |
| Ranolazine ErRanolazine | 21 | $1,532 |
| Nifedipine ErNifedipine | 18 | $723 |
| ClopidogrelClopidogrel Bisulfate | 55 | $548 |
| Losartan Potassium | 75 | $526 |
| Ezetimibe | 16 | $474 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 41 | $439 |
| Amlodipine Besylate | 65 | $407 |
| Lisinopril | 84 | $397 |
| Carvedilol | 71 | $384 |
| Metoprolol Tartrate | 47 | $298 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Kew Gardens
- Roger HajjarNew York$5.2M
- Szilard VorosStony Brook$3.7M
- Gregg StoneNew York$2M
- Augustin DelagoAlbany$1.8M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Luigi di BiaseBronx$978K
- Vijay IyerAmherst$855K
- Megha PrasadNew York$813K
- Ronald DagostinoLake Success$782K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.